Platelet Rich Plasma (PRP) Market Report

Platelet Rich Plasma (PRP) Market Analysis By Product (Pure, Leukocyte-Rich, Leukocyte-Rich Fibrin), By Application (Orthopedics, Cosmetic Surgery, Ophthalmic Surgery, Neurosurgery), And Segment Forecasts, 2014 - 2025

Published: June 2017  |  100 Pages  |  Format: PDF  |  Report ID: GVR-1-68038-869-5

Industry Insights

The global platelet rich plasma (PRP) market size was valued at USD 214.3 million in 2016 and is expected to grow at a CAGR of 13.3% over the forecast period. Platelet-rich plasma combines modern technology with the body's own ability to heal itself and is used in various medical applications including orthopedics, neurosurgery, ophthalmology, cosmetic surgery, and others. PRP therapy involves the collection of a small sample of individual’s own blood and placing it in a centrifuge for separating platelets from other components. The platelet is then injected into and around the point of injury for faster healing process. There is absolutely no risk of infection and allergic reactions to the patient as the individual’s own blood is used in the process.

U.S. platelet-rich plasma (PRP) market revenue, by product, 2014 - 2025 (USD Million)

U.S. platelet-rich plasma (PRP) market

Growing geriatric population and rising orthopedic conditions are expected to boost the growth of the market. According to the National Center for Biotechnology Information, every year, around 1.5 million individuals suffer an osteoporotic-related fracture. In addition, growing awareness about platelet rich plasma treatment in dental health is expected to fuel growth during the forecast period.

Government bodies of developing countries such as India, Mexico, and Brazil, are making huge investments to spread awareness regarding plasma therapy. The market for PRP is anticipated to grow at a lucrative rate as it has potential to assist in providing enhanced management of various orthopedic issues related to elbow, wrist, shoulder, hip, knee, back, and ankle, which are on the rise in developing regions.

Product Insights

Pure PRP dominated the product segment in 2016. Pure PRP eliminates red blood cells and neutrophils. Red blood cells and neutrophils, a type of white blood cell, have no therapeutic effect and also contain inflammatory components, which might increase pain post treatment.

However, leukocyte-rich fibrin is expected to grow at the highest CAGR during the forecast period. Leukocyte-rich fibrin results in improved healing response and significantly reduced recovery time. Moreover, they also contain natural healing proteins, creating a potential network of cells to accelerate the healing process for better bone regeneration.

Application Insights

The orthopedics application segment dominated the market in 2016. A number of orthopedic issues such as rotator cuff, quadriceps, hamstring, Achilles tendon injuries, and tennis elbow can be treated successfully with PRP. This treatment reduces chances of recurrence of the injury or the injury becoming severe, which might require surgical intervention or result in permanent disability.

Cosmetic surgery and dermatology is expected to witness the highest growth during the forecast period. Plasma therapy has become one of the most sought-after nonsurgical procedures for facial rejuvenation processes. PRP uses an individual’s own blood to stimulate new cell growth, improve complexion, skin texture, and restore lost facial volume.

Global platelet rich plasma (PRP) market revenue, by product, 2016 (%)

Global platelet rich plasma (PRP) market

Regional Insights

North America dominated the platelet-rich plasma sector with largest revenue share in 2016. Widening application areas of platelet rich plasma in therapeutics and increasing number of people suffering from orthopedic disorders are some of the factors responsible for the dominant growth of the market in this region. In addition, North America is home to some of the most significant players who are operating in the field of PRP market.

On the other hand, Asia Pacific is expected to exhibit fastest growth during the forecast period. Increasing number of cosmetic surgeries to enhance facial features in countries such as Korea, Thailand, and India is expected to drive growth in the Asia Pacific region. Moreover, increasing medical tourism industry in the region is expected to augment the adoption of PRP therapy in the region.

Competitive Insights

Currently, the global platelet rich plasma market is consolidated in nature with a few players competing with each other. Some of the top companies operating in this industry are T-Biotechnology (T-LAB); Arthrex, Inc.; Terumo BCT, Inc.; EmCyte Corporation; DePuy Synthes; Zimmer Biomet; Stryker; Glofinn Oy; DR. PRP AMERICA, LLC; and others.

Companies are developing devices that can facilitate safe and rapid preparation of autologous platelet-rich plasma. In addition, various companies are adopting cost-effective methods as one of their major strategies to increase the share during the forecast period.

Report Scope

Attribute

Details

Base year for estimation

2016

Actual estimates/Historical data

2014 - 2015

Forecast period

2017 - 2025

Market representation

Revenue in USD Million & CAGR from 2017 to 2025

Regional scope

North America, Europe, Asia Pacific, Latin America& MEA

Country scope

U.S., Canada, UK, Germany, China, Japan, Brazil, Mexico, & South Africa

Report coverage

Revenue, company share, competitive landscape, growth factors, trends

15% free customization scope (equivalent to 5 analysts working days)

If you need specific market information, which is not currently within the scope of the report, we will provide it to you as a part of customization


Segments Covered in the Report

This report forecasts revenue growth at global, regional & country levels as well as provides an analysis on the latest trends and opportunities in each of the sub-segments from 2014 to 2025. For the purpose of this study, Grand View Research has segmented the global platelet rich plasma market on the basis of product, application, and region:

  • Product Outlook (Revenue, USD Million, 2014 - 2025)

    • Pure PRP

    • Leukocyte Rich PRP

    • Leukocyte Rich Fibrin

  • Application Outlook (Revenue, USD Million, 2014 - 2025)

    • Orthopedics

    • Cosmetic Surgery & Dermatology

    • Ophthalmic Surgery

    • Neurosurgery

    • General surgery

    • Others

  • Regional Outlook (Revenue, USD Million, 2014 - 2025)

    • North America

      • U.S.

      • Canada

    • Europe

      • UK

      • Germany

    • Asia Pacific

      • Japan

      • China

    • Latin America

      • Brazil

      • Mexico

    • MEA

      • South Africa

Key questions answered by the report
Request for Customization

Choose License Type:

Single User - $4,950
Multi User - $7,950
Enterprise User - $9,950

Special Pricing & Discounts

Avail customized purchase options to meet your research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

  • Research support

    24/5 Research support

    Get your queries resolved from an industry expert. Request for a free product review before report purchase.

  • Custom research service

    Custom research service

    Speak to the report author to design an exclusive study to serve your research needs.

  • Quality assurance

    Quality assurance

    A testimonial for service excellence represented in the form of BBB "A" Accreditation.

  • BBB Rating dandb
  • Information security

    Information security

    Your personal and confidential information is safe and secure.

  • BOA